Loading
Life sciences · Journal article
Food Nutrition · August 12, 2026
Early or partial results. Treat as a signal, not a conclusion.
A preclinical study reports that a Dendrobium officinale polysaccharide–spermidine hydrogel (DS) reduced adiposity and improved metabolic markers in high-fat-diet mice via apparent enrichment of Bifidobacterium and elevated short-chain fatty acids. The mechanism is plausible but evidence is limited to controlled laboratory conditions and a single animal model; human efficacy and safety remain untested.
In vitro fermentation model combined with high-fat diet mouse model study. In vitro: human fecal microbiota source not detailed. In vivo: HFD-induced metabolic disorder mice; sex, age, strain, and housing not specified.. Intervention: Dendrobium officinale polysaccharide–spermidine hydrogel (DS) at DOP:Spd ratio 18:2; dose, duration, and route of administration in mice not stated. Compared with: In vitro: control group and DOP alone. In vivo: model group (HFD control); specific comparator arm details not provided.
DS promoted Bifidobacterium growth 6.69-fold and Lactobacillus 3.75-fold in in vitro fermentation versus control DS reduced epididymal fat index by 18.66% and subcutaneous fat index by 26.46% in HFD mice versus model group DS elevated hepatic CAT activity by 48.53% and GSH level by 77.43% in HFD mice
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
These findings suggest a potential mechanistic pathway for a functional food ingredient in obesity and metabolic dysfunction, but lack human evidence. Clinicians should not recommend this intervention pending human clinical trials demonstrating safety and efficacy.
Early-stage translational work combining in vitro fermentation and mouse model studies with no human trials; mechanistic findings in animal obesity models require confirmation in clinical populations before informing practice.
As stated by the source record.
Quoted from the source exactly as published.
These findings suggest a potential mechanistic pathway for a functional food ingredient in obesity and metabolic dysfunction, but lack human evidence. Clinicians should not recommend this intervention pending human clinical trials demonstrating safety and efficacy.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
The synergistic anti-aging effects of Dendrobium officinale polysaccharides (DOP) and spermidine (Spd) via metabolic regulation have been reported in Caenorhabditis elegans. Notably, DOP and Spd spontaneously formed a DOP–Spd hydrogel (DS) at a DOP:Spd ratio of 18:2. However, whether and how DS influences the gut microbiota and host metabolism remains unclear. In this study, an in vitro colonic fermentation model was used to investigate the effects of DOP and DS on gut microbial composition and metabolite profiles. Compared to the control group, DS significantly promoted the growth of Bifidobacterium and Lactobacillus by 6.69-fold and 3.75-fold, respectively. Compared with DOP alone, DS showed greater enrichment of Prevotella _2 (+111.06%), short-chain fatty acids (SCFAs; +34.16%), NAD + (27.83-fold), and adenosine (2.89-fold). PICRUSt-based KEGG functional prediction revealed downregulation of lipid metabolism, accompanied by a relative increase in amino acid and nucleotide metabolism pathways. To verify these effects in vivo, high-fat-diet (HFD)–induced metabolic disorder mice were used. Compared with the model group, DS treatment significantly reduced epididymal (−18.66%) and subcutaneous (−26.46%) fat indices, improved glucose tolerance, and enhanced hepatic antioxidant capacity with CAT activity and GSH level increasing by 48.53% and 77.43%, respectively. Moreover, DS reshaped the gut microbiota increasing Lactobacillus and Bifidobacterium while suppressing Helicobacter, elevated fecal SCFA levels, and increased metabolites (α-linolenic acid, nicotinic acid) involved in unsaturated fatty acid biosynthesis and purine metabolism. Spearman correlation analysis showed that Bifidobacterium was associated with the largest number of metabolites and biochemical indicators, being significantly positively correlated with hepatic GSH, propionic acid, and adenosine, and significantly negatively correlated with hepatic TG. In conclusion, DS ameliorates lipid metabolic disturbances and oxidative stress by modulation of the gut microbiota and key metabolites (SCFAs, nicotinic acid, NAD + ), highlighting its potential as a functional food ingredient for supporting glucose and lipid metabolic health.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.